Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • Patient Narratives

UK study reveals sex-specific health risks following type 2 diabetes diagnosis

Research from Queen Mary University of London highlights distinct health trajectories for men and women after a type 2 diabetes diagnosis, underscoring the need for personalised treatment approaches to address mental health in women and cardiovascular risks in men. A…

  • apxadmin
  • September 3, 2026
  • News & Research

UK study reveals sex-specific risks in post-diagnosis complications of type 2 diabetes

New research from Queen Mary University of London highlights significant differences in mental health and cardiovascular risks for women and men following a type 2 diabetes diagnosis, calling for more personalised care approaches. A UK study published in PLOS Medicine…

  • apxadmin
  • September 3, 2026
  • Glycaemic Index

Nutrition experts emphasise the importance of quality over elimination in carbohydrate intake

Contrary to popular dieting trends, a clinical expert highlights the significance of choosing the right types of carbohydrates for sustained energy and overall health, advocating for a balanced diet over complete restriction. Many people cut carbohydrates almost entirely when they…

  • apxadmin
  • September 3, 2026
  • Patient Narratives

Yale study finds no clear advantage of GLP-1 drugs in helping type 2 diabetes patients stop insulin

A recent Yale-led study suggests that GLP-1 receptor agonists do not significantly increase the likelihood of insulin cessation among type 2 diabetes patients compared to other common medications, raising questions about their role in insulin withdrawal strategies. A Yale-led study…

  • apxadmin
  • September 3, 2026
  • News & Research

Study questions the effectiveness of GLP-1 drugs in helping some type 2 diabetes patients stop insulin

A Yale-led study finds GLP-1 receptor agonists may lower insulin use in some type 2 diabetes patients but do not significantly increase the likelihood of stopping insulin entirely, highlighting ongoing challenges in medication management. A Yale-led study has found that…

  • apxadmin
  • September 3, 2026
  • News & Research

FDA tightens controls on compounded GLP-1 weight-loss injections amid surge in fraud and safety concerns

Regulators increase scrutiny over the import, labelling, and safety of compounded GLP-1 weight-loss drugs, warning of counterfeit products and dangerous ingredients in circulation across the US and globally. Federal regulators have moved to tighten control over the ingredients used in…

  • apxadmin
  • September 3, 2026
  • Patient Narratives

Smart shopping tips for affordable low-carb eating without the extra cost

A closer look at how adjusting your shopping habits and meal plans can make a low-carb diet more affordable, without resorting to costly speciality products, guided by expert advice and common sense. Changing the way you eat can be far…

  • apxadmin
  • September 3, 2026
  • News & Research

Practical tips for affordable macro tracking and flexible dieting

A guide to understanding macronutrients and meal planning that can help you adopt a flexible diet without costly specialised products, emphasising practicality and personalised adjustments. Changing the way you eat can be expensive if the first thing you do is…

  • apxadmin
  • September 3, 2026
  • Glycaemic Index

Eating apples and pears can support blood sugar control, recent research shows

Contrary to long-standing fears, apples and pears are both suitable for blood sugar regulation due to their fibre, water and plant compounds, with practical advice emphasising fibre retention and pairing with healthy fats for best results. People trying to manage…

  • apxadmin
  • September 3, 2026
  • News & Research

New insights into brain circuits offer targeted pathways for obesity treatment

Researchers uncover how distinct brain regions mediate the effects of GIPR agonists and antagonists on appetite and weight loss, paving the way for more personalised obesity therapies. Researchers have identified two separate brain circuits that help explain why both stimulating…

  • apxadmin
  • September 2, 2026
Prev
1 … 124 125 126 127 128 129 130 … 200
Next

Search

No results

Posts

Pharma Dynamics expands diabetes support beyond glucose tracking with MyDynamics platform

October 23, 2026

Turkish health official warns of rising health risks linked to starch-based sugar consumption

August 18, 2026

New insights challenge the direct role of FTO in metabolic diseases

October 7, 2026

Avaí Bio and Austrianova test immune-shielded stem cell therapy for insulin-dependent diabetes

October 12, 2026

FDA warnings highlight risks of Trividia Blood Glucose Meter amidst shift to connected diabetes devices

September 30, 2026

Trending now

Bamboo extract dampens diabetes-linked cell stress in rats, study finds
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy